Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome.

@article{Thomas1995ExpressionON,
  title={Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome.},
  author={X. Thomas and Luis Vila and Lydia Campos and Odile Sabido and Eric Archimbaud},
  journal={Leukemia & lymphoma},
  year={1995},
  volume={19 3-4},
  pages={295-300}
}
Expression of CD56 was analyzed by indirect immunofluorescence method on bone marrow samples from 94 newly diagnosed patients with acute leukemia (AL), including 59 acute myelogenous leukemias (AML) and 35 acute lymphoblastic leukemias (ALL). CD56 was expressed on 17 +/- 18% (range: 0-72%) of AML cells and 24 +/- 24% (range: 0-98%) of ALL cells, without significant differences between FAB subtypes in AML, nor immunologic subtypes in ALL. Expression of CD56 was not associated with any clinical… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis

Journal of Cancer Research and Clinical Oncology • 2015
View 4 Excerpts
Highly Influenced

High incidence of CD56 expression and relapse rate in acute myeloid leukemia patients with t(8;21) in Taiwan.

Journal of the Formosan Medical Association = Taiwan yi zhi • 2002
View 3 Excerpts

Similar Papers

Loading similar papers…